A third popular drug now being used for weight loss is Mounjaro, whose active ingredient, tirzepatide, works by activating two naturally produced hormones in the body: glucagon-like peptide-1, known as GLP-1, and glucose-dependent insulinotropic polypeptide, or GIP
We recommend seeing a dietitian if you: Have been diagnosed with diverticular disease and want some support on dietary management of this condition Would like to optimise the healing rate of diverticula Are struggling with any of the symptoms of diverticular disease Need nutritional advice to help ensure you're meeting your individual nutrient requirements Would like advice on ways to have more high-fibre foods in your diet Would like personalised advice and support from a professional
Similar observations have been made in the 5xFAD mouse model [163]
4 Eli Lilly has said it expects to file for regulatory approval once the remaining TRIUMPH trials report results in 2026, and UK approval would follow shortly after
The relationship among DPP-4 activity, increased GLP-1, and plasma TGs is disrupted in HFD-fed mice
dose-dependent GI adverse events (nausea, vomiting) similar to other amylin analogues Exposure: Dose-proportional increases in Cmax and AUC Gastric Effects: Dose-dependent slowing of gastric emptying confirmed via paracetamol absorption test Appetite Suppression: Reduced ad libitum food intake at doses 1.2 mg Clinical Significance: Established feasibility of once-weekly dosing and identified dose range for Phase 2 studies
